The tumor cell lines (MDA-MB-453, THP-1, RH30, RH41, TE671, A204, Renca-lacZ, Renca-lacZ/erbB-2), peripheral blood mononuclear cells (PBMCs) and the primary aRMS VJ cells were analyzed for the expression of the NKG2D ligands ULBP-2/5/6, and MIC A/B, as well as for the expression of ErbB2 (HER2/neu) (Table 1). The gene discussed is ERBB2; the disease is neoplasm.